Sat.Jun 15, 2024 - Fri.Jun 21, 2024

article thumbnail

Pharmacy in the Digital Age

Drug Topics

The world’s information is at our fingertips, but understanding that information and applying it to patient care still requires a rigorous education.

article thumbnail

BENEFIT Trial Results Show Quadruplet Regimen for NDMM TI May Require Weighing Efficacy vs Safety

Pharmacy Times

The quadruplet regimen added bortezomib to the current standard of care, which is a triplet regimen of isatuximab, lenalidomide, and dexamethasone for patients with transplant-ineligible, newly diagnosed multiple myeloma (NDMM TI).

139
139
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Vertex reports positive results in stem cell trial for type 1 diabetes

STAT

ORLANDO — Twelve people with type 1 diabetes who received a therapy derived from stem cells were able to produce enough of their own insulin to maintain healthy blood glucose levels 90 days later, Vertex Pharmaceuticals said Friday. All but one reduced or eliminated the need to inject insulin over those three months and three people followed for one year no longer needed to inject insulin at all.

145
145
article thumbnail

Watch out, GSK. Gilead’s twice-yearly PrEP drug shows 100% efficacy for HIV prevention

Fierce Pharma

For the first time, an HIV PrEP drug candidate has shown zero infections in a phase 3 trial. | For the first time, an HIV PrEP drug candidate has shown zero infections in a phase 3 trial. For Gilead, it serves as one of two pieces for a potential FDA filing. For GSK, it means a major competitor could be looming around the corner.

FDA 143
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Slideshow: Everything You Need to Know About the US Bird Flu Outbreak

Drug Topics

In a webinar conducted by the National Foundation for Infectious Diseases (NFID), experts gathered to publicly address the ongoing bird flu outbreak across many US states.

223
223
article thumbnail

FDA Commissioner Says the United States Is Failing the Type 2 Diabetes Epidemic

Pharmacy Times

With improved technology and innovations for diabetes, it is essential for health care providers and health agencies to collaborate to combat rising rates of diabetes.

FDA 138

More Trending

article thumbnail

‘A mixed bag’: Fifth Circuit rules on ACA preventive services legal case

Fierce Healthcare

The Fifth Circuit Court of Appeals has issued a decision in a major legal case that observers have said could fundamentally alter the preventive services provision in the Affordable Care Act. | The Fifth Circuit Court of Appeals has issued its ruling on Braidwood Management v. Becerra, a case that has wide-ranging implications on millions of Americans.

130
130
article thumbnail

Increasing Prevalence of T1D Calls for Age-Specific Clinical Guidelines of Management

Drug Topics

Clinical recommendations for the management of type 1 diabetes (T1D) in older adults are urgently needed as the global population ages and as improved diabetes care and management of complications have extended the life expectancy of the patient population.

199
199
article thumbnail

Speaking a Second Language Has Countless Benefits in the Pharmacy Setting

Pharmacy Times

Being able to communicate in a different language can improve treatment adherence and medication efficacy outcomes

article thumbnail

Supreme Court outlawed segregation of disabled people 25 years ago. But change has come slowly

STAT

As a toddler, Veronica Ayala loved Fridays. At 5 o’clock sharp, her mom whisked her away from the grim Moody State School for Cerebral Palsied Children for a 48-hour reprieve. Ayala’s house was mere minutes away, but the doctors insisted that she had to live at the Galveston, Texas institution during the week so she could learn how to walk.

143
143
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Color Health taps OpenAI to generate screening plans for cancer patients

Fierce Healthcare

Color Health is working with OpenAI to test out computer-generated personalized care plans for cancer patients. | Color developed a new copilot app that leverages GPT-4o to identify missing diagnostics and create tailored workup plans for patients.

136
136
article thumbnail

Value-Based Care Models Can Help Pharmacies Improve Operations

Drug Topics

Sandra C. Canally, RN, founder and CEO of The Compliance Team, discussed the goals, benefits, and opportunities of value-based care in pharmacy.

201
201
article thumbnail

Study Finds Asthma Severity is Not Associated With Reactivity to Allergen Skin Testing

Pharmacy Times

The findings also show that skin testing positivity for perennial allergens was higher in patients with childhood-onset asthma compared with those with adult-onset asthma.

137
137
article thumbnail

Opinion: Long Covid feels like a gun to my head

STAT

I have spent my career studying infectious diseases that fall under the heading of neglected tropical diseases. Now I have a neglected disease — long Covid — an incurable (for now and for me) disease. As a medical anthropologist working in global health, I thought I understood the despair of poor health. I didn’t. I join 7% of the U.S. adult population — or about 18 million Americans — who have experienced long Covid.

145
145
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Amazon Pharmacy expands RxPass subscription service to Medicare patients

Fierce Healthcare

Amazon Pharmacy is expanding its prescription drug subscription program, called RxPass, to Prime members on Medicare insurance. | The RxPass program, launched in January 2023, provides unlimited access to 60 eligible generic medications and will ship the medications to customers' homes for a flat monthly fee of $5.

Insurance 135
article thumbnail

How to Improve Medication Adherence Within the Pharmacy

Drug Topics

Medication nonadherence can account for up to 50% of treatment failures and over $500 billion in annual health care costs.

201
201
article thumbnail

Study: Ultraviolet-B Radiation Could Improve Widespread Vitamin D Deficiency

Pharmacy Times

Ambient-UVB radiation could improve 25(OH)D prediction in the future, improving widespread vitamin D deficiencies among non-White individuals.

144
144
article thumbnail

Substance use experts are sounding the alarm on another addiction: gambling

STAT

LAS VEGAS — Downstairs was a sensory overload: Roulette wheels spun, slot-machine chimes rang, and dealers hurried to scoop up stacks of casino chips resting in front of busted blackjack hands. Many gamblers held a drink in one hand and a cigarette in the other.  It was perhaps a strange setting for a conference about substance use treatment.

141
141
article thumbnail

Merck gets shot in the arm with FDA approval for first pneumococcal vaccine designed for adults

Fierce Pharma

The FDA has approved the world’s first pneumococcal disease vaccine designed for adults, signing off on Merck’s Capvaxive (formerly V116) and positioning it to become the primary shot used by senio | The FDA has approved the world’s first pneumococcal disease vaccine designed for adults, signing off on Merck’s Capvaxive (formerly V116) and positioning it to become the primary shot used by seniors to protect against the bacterial infection.

Vaccines 133
article thumbnail

Slideshow: Exploring Cannabis Utilization in the Oncology Landscape

Drug Topics

Four abstracts presented at ASCO 2024 delved into cannabis and pain management, potential medication interactions, and symptom mitigation, in patients with cancer.

157
157
article thumbnail

Drug Shortages in Community Oncology: Ensuring Access to Chemotherapy

Pharmacy Times

Persistent chemotherapy drug shortages challenge oncology providers. American Oncology Network employs a drug shortage committee for organized shortage management that involves pharmacists and interdisciplinary stakeholders.

article thumbnail

Change Healthcare to begin notifying patients that cyberattack compromised their private info

STAT

Change Healthcare is beginning the process of notifying a “substantial proportion” of Americans that their private information, such as Social Security numbers and medical diagnoses, was compromised in the cyberattack that brought portions of the U.S. health care system to a halt earlier this year. On Thursday, Change will begin to notify health care providers, insurance companies, and other customers that their patients’ data was stolen in the company’s February cybe

Insurance 139
article thumbnail

Value-based care, GLP-1s: 4 takeaways from AHIP 2024

Fierce Healthcare

LAS VEGAS — Last week, leaders across the health insurance industry descended on Sin City to dig deep into the biggest topics facing payers. | LAS VEGAS — Last week, leaders across the health insurance industry descended on Sin City to dig deep into the biggest issues facing payers.

Insurance 131
article thumbnail

Dermatologic Follow-Up Adherence Associated with Reduced Melanoma Mortality

Drug Topics

The strongest independent predictors of becoming adherent to dermatology follow-up included younger age and prior outpatient visits.

145
145
article thumbnail

FDA Approves Blinatumomab for Adult and Pediatric Patients With B-ALL

Pharmacy Times

The FDA approved blinatumomab for treatment of patients with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

FDA 139
article thumbnail

New Merck pneumococcal vaccine wins FDA approval

STAT

The Food and Drug Administration on Monday approved Merck’s new pneumococcal vaccine for adults 18 and older. The vaccine, which will be sold under the name Capvaxive, is designed to protect against pneumococcal pneumonia, which hospitalizes about 150,000 adults in the United States every year and kills about 1 in 20 who develop it, according to the National Foundation for Infectious Diseases.

Vaccines 144
article thumbnail

Done responds to fraud charges, 'stands by' integrity of its services even as former employees raise the alarm

Fierce Healthcare

Telehealth startup Done said it "disagrees" with the criminal charges filed last week against its founder, Ruthia He, and David Brody, M.D., and plans to continue operating. | Telehealth startup Done said it "disagrees" with the criminal charges filed last week against its founder, Ruthia He, and David Brody, M.D. and plans to continue operating.

122
122
article thumbnail

Kansas AG accuses Pfizer of misrepresenting COVID vaccine, hiding safety risks in lawsuit

Fierce Pharma

Kansas Attorney General is accusing Pfizer of "misrepresenting" its vaccine's safety and efficacy in a 179-page civil suit.

Vaccines 145
article thumbnail

FDA Approves Pembrolizumab With Chemotherapy to Treat Adult Patients With Endometrial Carcinoma

Pharmacy Times

The indication is for adult patients with primary advanced or recurrent endometrial carcinoma and is the third indication that pembrolizumab has received for this disease state.

article thumbnail

Inside Anthony Fauci’s ‘On Call’: 9 health and science takeaways from the memoir of America’s most famous doctor

STAT

Anthony Fauci spent 40 years in the top echelons of government. It was no accident. To read the forthcoming memoir by the country’s former top infectious disease expert, “On Call: A Doctor’s Journey in Public Service,” a copy of which was obtained by STAT, is to get a sense of his finesse while advising seven presidents. He strove, he writes, to speak with complete candor and stay out of politics, while remaining strategic in pushing for policies he considered vital t

145
145
article thumbnail

Novavax seeks FDA approval for updated Covid-19 vaccine

Pharmaceutical Technology

Novavax has sought US FDA approval for an updated JN.1 version of its Covid-19 vaccine, NVX-CoV2705, for individuals aged 12 years and above.

Vaccines 145
article thumbnail

Sarepta scores 'transformational' FDA label expansion for Duchenne gene therapy Elevidys

Fierce Pharma

There’s no slowing the momentum of Sarepta’s groundbreaking Duchenne muscular dystrophy (DMD) gene therapy Elevidys—not even the failure of a confirmatory trial. | The FDA has expanded the label for Sarepta's Elevidys to all Duchenne muscular dystrophy patients ages 4 and older. It’s a major boost for the first gene therapy to treat the inherited disorder, which received an accelerated approval a year ago—nearly to the date—but only for ambulatory boys ages 4 to 5.

Labelling 123
article thumbnail

AHIP 2024: Not just a buzzword—payers envision AI’s future

Fierce Healthcare

You can’t spell AHIP without AI. | Health insurance executives are captivated by artificial intelligences' use cases. Here's where they see advancements on the horizon.

Insurance 124
article thumbnail

Another heat wave is hitting the U.S. Here’s what you need to know

STAT

Extreme heat is coming this week in many parts of the United States. The Midwest and Northeast in particular will see weather that puts them in the National Weather Service’s highest heat risk category — when lack of cooling or hydration can put almost anyone in harm’s way. It’s a new labeling system for the NWS, which launched the experimental rating at the end of April with the Centers for Disease Control and Prevention in response to the growing danger of extreme h

Labelling 142